Secondary prevention of vascular disease by prolonged antiplatelet treatment-Reference-Cited by-同舟云学术

Secondary prevention of vascular disease by prolonged antiplatelet treatment

Published:1988-01-30 Issue:6618 Volume:296 Page:320-331
ISSN:0959-8138
Container-title:BMJ
language:en
Short-container-title:BMJ

Author:

Publisher

BMJ

Subject

General Earth and Planetary Sciences,General Environmental Science,General Engineering

Reference53 articles.

1. European stroke prevention study: principal end points;Group, European Stroke Prevention Study;Lancet,1987

2. Essai coopdratifcontr6le "AICLA." Prevention secondaire des accidents ischemiques cerebraux lies a l'atherosclerose par l'aspirine et le dipyridamole;Bousser, M.G.; Eschwege, E.; Haguenau, M.; Lefauconnier, J.M.; Touboul, D.; Touboul, P.J.;Rev Neurol (Pan's),1981

3. "AICLA" controlled trial of aspirin and dipyridamole in the secondary prevention of atherothrombotic cerebral ischemia;Bousser, M.G.; Eschwege, E.; Haguenau, M.;Stroke,1983

4. Canadian Cooperative Study Group. A randomized trial of aspirin and sulfinpyrazone in threatened stroke;N EnglJ Med,1978

5. High dose salicylic acid after cerebral infarction;Britton, M.; Helmers, C.; Samuelsson, K.;Stroke,1986

Cited by 909 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimal Medical Therapy for Chronic Coronary Disease in 2024: Focus on Antithrombotic Therapy;Medical Clinics of North America;2023-12

2. Ischaemic stroke despite antiplatelet therapy: Causes and outcomes;European Stroke Journal;2023-05-24

3. Endovascular thrombectomy for acute ischemic stroke;Journal of Internal Medicine;2022-02-16

4. Sekundärprävention: Thrombozytenfunktionshemmung (TFH);Schlaganfall evidenzbasiert behandeln;2022

5. Neuroophthalmologic Disease of the Retina;Albert and Jakobiec's Principles and Practice of Ophthalmology;2022